We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase 3 Studies of Merck's Bezlotoxumab Successful

News   Sep 22, 2015

 
Phase 3 Studies of Merck's Bezlotoxumab Successful
 
 
 

RELATED ARTICLES

Influenza Virus Molecules Set Immune Response Into Overdrive

News

Mini viral RNA plays a key role in the immune response that is triggered by influenza infections.

READ MORE

Pre-clinical Success Offers Hope for Universal Flu Vaccine

News

The identification of epitopes with limited variability offers a mechanism by which a universal vaccine can be created.

READ MORE

Fire, Sun or Electricity Powers Hand-held Cancer Detection Device

News

Device shows promise as a point-of-care detector of Kaposi sarcoma-associated herpesvirus in resource-limited settings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE